19.23
2.44%
-0.48
Handel nachbörslich:
19.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ARWR?
Forum
Prognose
Aktiensplit
Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.00%
-
|
3.551 | 16.10 | 15.82 | 146.27 |
Operating Expenses |
9.93%
126.19
|
140.10 | 124.43 | 118.53 | 98.10 |
Interest Income/Expense |
34.97%
7.244
|
5.367 | 5.262 | 5.158 | 5.057 |
Benefits Costs and Expenses |
10.72%
127.00
|
142.24 | 125.09 | 119.21 | 98.59 |
Costs And Expenses |
10.72%
127.00
|
142.24 | 125.09 | 119.21 | 98.59 |
Depreciation and Amortization |
6.15%
4.525
|
4.263 | 3.859 | 3.276 | 2.669 |
Operating Income/Loss |
7.58%
-126.19
|
-136.54 | -108.33 | -102.70 | 48.16 |
Nonoperating Income/Loss |
62.45%
-0.805
|
-2.144 | -0.66 | -0.68 | -0.489 |
Income/Loss From Continuing Operations Before Tax |
8.43%
-127.00
|
-138.69 | -108.99 | -103.38 | 47.68 |
Income Tax Expense/Benefit |
100.00%
-
|
-3.313 | 2.025 | 0.742 | - |
Income/Loss From Continuing Operations After Tax |
6.19%
-127.00
|
-135.38 | -111.02 | -104.12 | 48.67 |
Net Income/Loss
|
6.19%
-127.00
|
-135.38 | -111.02 | -104.12 | 47.68 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
32.48%
-1.696
|
-2.512 | -1.336 | -1.179 | -0.999 |
Basic Average Shares |
14.77%
123.28
|
107.42 | 0.153 | 107.00 | 106.76 |
Diluted Average Shares |
14.77%
123.28
|
107.42 | 0.153 | 107.00 | 108.14 |
Basic Earnings Per Share |
17.74%
-1.02
|
-1.24 | -1.02 | -0.96 | 0.46 |
Diluted Earnings Per Share |
17.74%
-1.02
|
-1.24 | -1.02 | -0.96 | 0.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):